Burford Capital Logo Light Burford Capital Logo Dark

Unlocking the value of pharmaceutical IP assets

June 28, 2022
Joshua Harris


Outside capital has powerful applications for pharma brands, universities and generics manufacturers seeking to de-risk and pursue valuable IP assets, and may spell the difference between success and failure in costly and protracted patent suits.

In the past decade IP litigation has grown more costly and risky,1 but none more so than pharmaceutical patent litigation. Unlike ordinary IP disputes, the complexity of pharmaceutical patents and associated regulatory hurdles amplify risk. And even if a claiman…

Provide your information below to view this page.